Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q3 2015 · 10-Q
Revenue$2.78B$2.78B+10.6% vs Q3 2014 Net Income$965.60M$965.60M+12.7% vs Q3 2014 EPS Diluted$4.15$4.15+14.6% vs Q3 2014 Gross Profit$2,467,900,000+11.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flowderived$895,400,000−2.0% Free Cash Flowderived$666,200,000−21.8% Margins · derivedGross margin88.8%+0.9 pt vs Q3 2014
Operating margin49.4%+3.5 pt vs Q3 2014
Net margin34.8%+0.6 pt vs Q3 2014
ended Sep 30, 2015 · filed Oct 21, 2015 · 21 d after period end